{
    "2021-12-03": [
        [
            {
                "time": "2021-12-03",
                "original_text": "恒瑞医药9个药品纳入国家医保目录",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "国家医保",
                        "药品"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-03",
                "original_text": "新版国家医保目录公布，恒瑞已上市8款创新药全部进入医保",
                "features": {
                    "keywords": [
                        "新版医保",
                        "恒瑞医药",
                        "创新药"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-03",
                "original_text": "70万一针“天价药”纳入医保，多家上市公司公告来了",
                "features": {
                    "keywords": [
                        "天价药",
                        "医保",
                        "上市公司"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-03",
                "original_text": "国家医保谈判结果出炉：“天价罕见病药”成功入选，国产“网红”PD-1成大赢家",
                "features": {
                    "keywords": [
                        "医保谈判",
                        "天价罕见病药",
                        "国产",
                        "PD-1"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-02",
                "original_text": "A股融资融券日报：两融余额减少72.45亿元",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-02",
                "original_text": "暴跌61%！FDA拒批万春药业普那布林上市，波及恒瑞医药",
                "features": {
                    "keywords": [
                        "暴跌",
                        "FDA",
                        "万春药业",
                        "恒瑞医药"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}